1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; He, M; Ni, X; Sun, Y; Tang, G; Wang, L; Xu, B; Yu, Y | 1 |
| Axelrad, TW; Bazan, HE; Bazan, NG; Deo, DD; Hunt, JD; Ottino, P; Van Kirk, J | 1 |
| Dong, Q; Kurek, C; Patel, MI | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Prostatic Neoplasms
| Article | Year |
|---|---|
The arachidonic acid pathway and its role in prostate cancer development and progression.
Topics: Animals; Annexins; Arachidonic Acid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Disease Progression; Group II Phospholipases A2; Humans; Lipoxygenase; Male; Oxygenases; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms | 2008 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Prostatic Neoplasms
| Article | Year |
|---|---|
Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Androgen Receptor Antagonists; Androgens; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclofenil; Dihydrotestosterone; Disease Progression; Estradiol; Hormone Antagonists; Humans; Imidazoles; Indoles; Male; Mifepristone; Platelet Activating Factor; Prostatic Neoplasms; Protein Kinase Inhibitors; RNA Interference; RNA, Small Interfering; Wnt Proteins | 2013 |
Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Movement; Cells, Cultured; Culture Media, Conditioned; Endothelial Cells; Enzyme Activation; Enzyme Precursors; Gene Expression Regulation; Growth Substances; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Membrane Proteins; Metalloendopeptidases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostatic Neoplasms; Receptors, G-Protein-Coupled; RNA, Messenger; Second Messenger Systems; Tissue Inhibitor of Metalloproteinase-2; Umbilical Veins | 2004 |